Increased expression of the transcription factor one-cut domain 2 (ONECUT2) has been observed in various cancers, including colorectal cancer, which is associated with tumor growth, metastasis, chemoresistance, and poor prognosis and is considered a potential therapeutic target in CRC [50]. This evidence concerns the gene ONECUT2 and cancer.